Radiopharm Theranostics Share Price and Company Fundamentals



Price
$0.165
Change
-0.010 (-5.714%)
52 week
0.13 - 0.495

Last traded: Today at 4:42 AM

Radiopharm Theranostics Limited develops radiopharmaceutical products for diagnostic and therapeutic uses. The company was incorporated in 2021 and is based in Carlton South, Australia.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

0.00%

Beta

-

Market cap

-

Enterprise value

-

Company profile

Primary activitiesClinical stage radiotherapeutics company
Industry / SectorBiotechnology / Healthcare
Websitehttps://www.radiopharmtheranostics.com
Mailing address62 Lygon Street Level 3 Carlton VIC 3053 Australia
Phone / Fax61 3 9824 5254 / 61 3 9822 7735
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Radiopharm Theranostics Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

Radiopharm Theranostics paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is . The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.

RAD's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Radiopharm Theranostics.

NameTitleAgeTotal Pay
Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICDFounder & Exec. Chairman65
Mr. Riccardo CanevariMD, CEO & Director
Mr. Phillip HainsCFO & Company Sec.
Mr. Vittorio Puppo M.D.Chief Operating Officer
Dr. Thomas H. Tulip Ph.D.Chief Technical Officer68
Prof. David MozleyChief Medical Officer & Scientific Advisory Board Chair
Dr. Scot L. Harper Ph.D.Sr. VP of Clinical Operations64

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

0.00%

Return on assets

-29.84%

Return on equity

-96.82%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Radiopharm Theranostics is and its enterprise value is .

Companies similar to Radiopharm Theranostics (RAD)

Radiopharm Theranostics (ASX:RAD) Frequently Asked Questions

1. What is Radiopharm Theranostics's Stock Symbol?

Radiopharm Theranostics trades on ASX under the ticker symbol "RAD".

2. What is Radiopharm Theranostics's stock price today?

One share of RAD stock can currently be purchased for approximately $0.165.

3. How can I contact Radiopharm Theranostics?

Radiopharm Theranostics's mailing address is 62 Lygon Street Level 3 Carlton VIC 3053 Australia. The company can be reached via phone at 61 3 9824 5254.

4. What is Radiopharm Theranostics's official website?

The official website of Radiopharm Theranostics is https://www.radiopharmtheranostics.com.

5. Which share registry manages Radiopharm Theranostics's stock?

Radiopharm Theranostics's stock is managed by AUTOMIC REGISTRY SERVICES.